Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
10.1016/j.arth.2025.07.015 28 LeeS.SinghK.ClarkS
At our practice, your safety and well-being come first
The ongoing RAPID I clinical trial is currently evaluating its safety and efficacy in patients with AP
My vial has less liquid than expected
(verified owner) This product has reduced my appitite
Ibrance (palbociclib) Disease area(s): Oncology Manufacturer(s): Pfizer 2024 Sales (USD): $4.37 billion Why it sold so well: Pfizers Ibrance generated $4.37 billion in global revenue in 2024, maintaining its position as a leading therapy for hormone receptor-positive (HR+), HER2-negative metastatic breast cancer
US$ 20.07
US$ 22.23
US$ 20.00
US$ 20.22
US$ 28.47
US$ 23.35
